Fortem Financial Group, LLC Innoviva, Inc. Transaction History

Fortem Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 20, 2021	SELL	$11.06 - $12.87 $23,369 - $27,194	-2,113 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$9.33 - $12.48 $19,714 - $26,370	2,113 New	2,113 $26,000
Q2 2019 Aug 09, 2019	SELL	$13.1 - $14.95 $181,173 - $206,758	-13,830 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$13.69 - $20.06 $971 - $1,424	71 Added 0.52%	13,830 $194,000
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $192,075 - $251,239	13,759 New	13,759 $240,000

240

77M

53.9K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.26B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortem Financial Group, LLC with notifications on news.